Skip to content

Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China

A Nationwide Treatment Survey of Intracranial Arteriovenous Malformation: a Multicenter Retrospective and Prospective Register Study in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01803685
Acronym
NTSIAVMC
Enrollment
1000
Registered
2013-03-04
Start date
2013-02-28
Completion date
2015-09-30
Last updated
2013-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Arteriovenous Malformations

Keywords

Intracranial Arteriovenous Malformations, Surgical removal, Endovascular embolism, Stereotaxic radiosurgery, Outcomes

Brief summary

This register study will collect the treatment information of the intracranial arteriovenous malformation patients in China. We aim to understand the current treatment situation of the disease in China.

Detailed description

Intracranial arteriovenous malformations are congenital lesions that consist of multiple arteries and veins, connecting as a fistula without intervening normal capillary bed. The treatment strategy including surgical removal, endovascular embolism and stereotaxic radiosurgery and comprehensive treatment. China is a united multi-ethnic nation of 56 ethnic groups, and has the largest population in the world. We have most extensive and valuable clinical resources of intracranial arteriovenous malformation in the world. But we know little about the current treatment situation of the disease in China. In order to realize the treatment situation of intracranial arteriovenous malformation in China, we designed a retrospective and prospective register study to collect the treatment and outcome information all over China.

Interventions

None listed

Sponsors

Dr. Yong Cao
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All the patients that diagnosed of intracranial AVM by DSA/CT/MRI * All patients gave written informed consent

Exclusion criteria

* patients refuse to attend the survey

Design outcomes

Primary

MeasureTime frameDescription
modified Ranking Scalesix months after operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead

Secondary

MeasureTime frameDescription
Treatment complicationssix months after treatmentPost operative epilepsy seizure, hemorrhage,infarction;cerebral edema、endovascular embolization injury

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026